RHS Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
RHS Financial's REGN Position: Q3 2026 in Review
RHS Financial opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 267 shares worth $202K. The stake represents 0.07% of the portfolio and ranks #181 among its holdings.
1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- RHS Financial held 267 shares of Regeneron Pharmaceuticals worth $202K as of Q3 2026.
- Regeneron Pharmaceuticals was a new RHS Financial position in Q3 2026.
- Regeneron Pharmaceuticals made up 0.07% of RHS Financial's portfolio in Q3 2026, its #181 holding.
- 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on RHS Financial's 13F filing for Q3 2026, filed 13 Oct 2026.